Company profile for Krystal Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Krystal Biotech, Inc. is a clinical-stage gene therapy company using its proprietary Skin TARgeted Delivery (STAR-D) platform to develop effective and innovative treatments for skin diseases. While we are initially developing topical and intradermal "off-the-shelf" novel therapies for rare and orphan dermatological indications, we are expanding the use of our pioneering STAR-D technology to target and treat other skin conditio...
Krystal Biotech, Inc. is a clinical-stage gene therapy company using its proprietary Skin TARgeted Delivery (STAR-D) platform to develop effective and innovative treatments for skin diseases. While we are initially developing topical and intradermal "off-the-shelf" novel therapies for rare and orphan dermatological indications, we are expanding the use of our pioneering STAR-D technology to target and treat other skin conditions as well. Our goal is to make a meaningful difference in the lives of underserved patient populations suffering from debilitating skin diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2100 Wharton St. #701 Pittsburgh, PA 15203
Telephone
Telephone
412-586-5830
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/26/3195083/0/en/Krystal-Biotech-to-Present-at-8th-Annual-Evercore-Healthcare-Conference.html

GLOBENEWSWIRE
26 Nov 2025

https://www.biospace.com/fda/krystal-biotechs-fda-platform-designation-pushes-limits-of-the-award

BIOSPACE
22 Oct 2025

https://www.globenewswire.com/news-release/2025/10/21/3170113/0/en/Krystal-Biotech-to-Report-Third-Quarter-2025-Financial-Results-on-November-3-2025.html

GLOBENEWSWIRE
21 Oct 2025

https://www.biospace.com/fda/krystal-biotechs-fda-platform-designation-pushes-limits-of-the-award

BIOSPACE
21 Oct 2025

https://www.biospace.com/fda/fdas-second-platform-designation-goes-to-krystal-after-sarepta-withdrawal

BIOSPACE
15 Oct 2025

https://www.globenewswire.com/news-release/2025/10/14/3166102/0/en/Krystal-Biotech-Receives-FDA-Platform-Technology-Designation-for-HSV-1-Viral-Vector-Used-in-KB801-for-the-Treatment-of-Neurotrophic-Keratitis.html

GLOBENEWSWIRE
14 Oct 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty